Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense TMZ plus CDDP in Recurrent Malignant Gliomas
NCT01670890Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2012
- Primary completion
- Aug 2014
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in malignant glioma, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT01670890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01670890.